Search bioRxiv⌕ Search

Biology subjects

Liotta, L.

Publications and source records attributed to Liotta, L..

2 recordsLinked to original sources

Biological networks with singular Jacobians: their origins and adaptation criteria

This work is focused on Ordinary Differential Equations(ODE)-based models of biochemical systems that possess a singular Jacobian manifesting in non-hyperbolic equilibria. We show that there are several classes of systems that exhibit this behavior: a)systems with monomial-type interaction terms and b)systems with linear or nonlinear conservation laws. While models derived from mass-action principles often present with linear conservation laws stemming from the underlying biologic rationale, nonlinear conservation laws are more subtle and harder to detect. Nevertheless, in both situations the corresponding ODE system will contain non-hyperbolic equilibria. While having a potentially more complex dynamics and falling outside of the scope of existing theoretical frameworks, this class of systems can still exhibit adapting behavior associated with certain nodes and inputs. We derive a generalized adaptation condition that extends to singular systems and is compatible with both single-input/single-output and multiple-input/multiple-output settings. The approach explored herein, based on the notion of Moore-Penrose pseudoinverse, is tested on several synthetic systems that are shown to exhibit homeostatic behavior but are not covered by existing methods. These results highlight the role of the network structure and modeling assumptions when understanding system response to input and can be helpful in discovering intrinsic relationships between the nodes.

systems biology↗

Development of a novel hybrid alphavirus-SARS-CoV-2 particle for rapid in vitro screening and quantification of neutralization antibodies, antiviral drugs, and viral mutations

Timely development of vaccines and antiviral drugs is critical to control the COVID-19 pandemic 1-6. Current methods for quantifying vaccine-induced neutralizing antibodies involve the use of pseudoviruses, such as the SARS-CoV-2 spike protein (S) pseudotyped lentivirus7-14. However, these pseudoviruses contain structural proteins foreign to SARS-CoV-2, and require days to infect and express reporter genes15. Here we describe the development of a new hybrid alphavirus-SARS-CoV-2 (Ha-CoV-2) particle for rapid and accurate quantification of neutralization antibodies and viral variants. Ha-CoV-2 is a non-replicating SARS-CoV-2 virus-like particle, composed of SARS-CoV-2 structural proteins (S, M, N, and E) and a RNA genome derived from a fast expressing alphavirus vector 16. We demonstrated that Ha-CoV-2 can rapidly and robustly express reporter genes in target cells within 3-6 hours. We further validated Ha-CoV-2 for rapid quantification of neutralization antibodies, viral variants, and antiviral drugs. In addition, as a proof-of-concept, we assembled and compared the relative infectivity of a panel of 10 Ha-CoV-2 variant isolates (D614G, P.1, B.1.1.207, B.1.351, B.1.1.7, B.1.429, B.1.258, B.1.494, B.1.2, B.1.1298), and demonstrated that these variants in general are 2-10 fold more infectious. Furthermore, we quantified the anti-serum from an infected and vaccinated individual; the one dose vaccination with Moderna mRNA-1273 has greatly increased the anti-serum titer for approximately 6 fold. The post-vaccination serum has also demonstrated various neutralizing activities against all 9 variants tested. These results demonstrated that Ha-CoV-2 can be used as a robust platform for rapid quantification of neutralizing antibodies against SARS-CoV-2 and its variants.

microbiology↗